D. Quast

发表

Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients

G. Möslein, Steffen Hoppe, R. Schneider, 2015, Familial Cancer.

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

J. Holst, C. Kapitza, M. Nauck, 2022, Diabetes, obesity & metabolism.

Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients

D. Todt, S. Pfaender, E. Steinmann, 2022, medRxiv.

Low risk of SARS-CoV-2 transmission by fomites - a clinical observational study in highly infectious COVID-19 patients.

G. Kampf, D. Todt, S. Pfaender, 2022, The Journal of infectious diseases.

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients

S. Pfaender, A. Reinacher-Schick, U. Kiltz, 2022, Journal of Cancer Research and Clinical Oncology.

Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.

W. Uhl, A. Tannapfel, W. Schmidt, 2016, European journal of endocrinology.

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes

C. Kapitza, M. Nauck, J. Meier, 2021, Diabetes, obesity & metabolism.

Another milestone in the evolution of GLP-1-based diabetes therapies

M. Nauck, J. Meier, D. Quast, 2021, Nature Medicine.

Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes

C. Kapitza, M. Nauck, J. Meier, 2020, Diabetes Care.

Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients

G. Kampf, D. Todt, S. Pfaender, 2022, The Journal of Infectious Diseases.

Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis

A. Mügge, M. Gotzmann, F. Kreimer, 2023, Frontiers in Cardiovascular Medicine.

Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center

A. Reinacher-Schick, D. Quast, O. Overheu, 2021, Oncology Research and Treatment.

Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption

G. Ellrichmann, A. Labedi, T. Breuer, 2020, Blood Purification.

Lemierre Syndrome After Tonsillectomy.

D. Quast, T. Lotz, T. Breuer, 2017, Deutsches Arzteblatt international.

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant

U. Stervbo, N. Babel, M. Hoffmann, 2022, Frontiers in Immunology.

Improvement of peripheral microcirculation after cardioversion of atrial fibrillation

A. Wutzler, T. Hummel, D. Quast, 2019, Pacing and clinical electrophysiology : PACE.

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

M. Nauck, J. Meier, Jakob Wefers, 2020, Molecular metabolism.

G. Möslein, Steffen Hoppe, R. Schneider, 2015, Familial Cancer.

The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update

A. Pfeiffer, M. Nauck, Jakob Wefers, 2021, Diabetes, obesity & metabolism.

A case series of verrucae vulgares mimicking hyperkeratosis in individuals with diabetic foot ulcers

M. Nauck, F. Bechara, D. Quast, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6

M. Nauck, D. Quast, 2021, Frontiers in Endocrinology.

Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide

M. Nauck, Mirna Abd El Aziz, D. Quast, 2023, Diabetes, obesity & metabolism.

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization

J. Becker, T. Gambichler, A. Tannapfel, 2022, Journal of Cancer Research and Clinical Oncology.

Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany

T. Gambichler, F. Bechara, J. Dietrich, 2023, International journal of molecular sciences.

Students in Dormitories Were Not Major Drivers of the Pandemic during Winter Term 2020/2021: A Cohort Study with RT-PCR and Antibody Surveillance in a German University City

D. Todt, E. Steinmann, H. Trampisch, 2021, COVID.

Digestive, Anorectal, and Urogenital Functions in Patients with Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and Normal Glucose Tolerance: Association with Autonomic Neuropathy

J. Meier, T. Breuer, D. Quast, 2022, Experimental and Clinical Endocrinology & Diabetes.

Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients

S. Pfaender, E. Steinmann, A. Reinacher-Schick, 2023, Journal of Cancer Research and Clinical Oncology.

Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes

M. Nauck, J. Meier, D. Quast, 2020, Diabetes Care.

Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.

W. Uhl, A. Tannapfel, W. Schmidt, 2016, European journal of endocrinology.